$16.00
15.99127900%
Last update: Nov 10, 4:05 AM
Mentari Therapeutics Inc (MTRI) Stock Price, Quote, News & History
MTRINASDAQ
You can purchase shares of Mentari Therapeutics (NASDAQ:MTRI) through any online brokerage.
Other companies in Mentari Therapeutics’s space includes: Eli Lilly and Co (NYSE:LLY), Johnson & Johnson (NYSE:JNJ), Merck & Co Inc (NYSE:MRK), Novartis AG (NYSE:NVS) and AstraZeneca PLC (NYSE:AZN).
Mentari Therapeutics has a consensus price target of $30.00.
The stock price for Mentari Therapeutics (NASDAQ: MTRI) is $15.67 last updated November 10, 2026 at 4:05 AM EST.
There are no upcoming dividends for Mentari Therapeutics.
Mentari Therapeutics does not have any upcoming earnings scheduled.
There is no upcoming split for Mentari Therapeutics.
Mentari Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.
Mentari Therapeutics Inc is a biotechnology company engaged in the development of therapies for the prevention of migraine. Its product pipeline includes MT-001, an anti-PACAP monoclonal antibody, and MT-002, a bispecific antibody targeting both CGRP...
